Podcasts about ce podcast

Découvrons ensemble le vocabulaire des matières scolaires grâce à une petite histoire compréhensible adaptée aux niveaux débutants.Apprends des structures utiles pour parler de tes préférences à l'école.Accès au MINI-SPRINT:https://www.sicomprendo.net/mini-sprint-de-vocabulaire/La newsletter.

Découvre les coulisses derrière la création de mon premier livre "Vocabulaire espagnol A1-A2 en 1000 mots: 200 cartes mentales et en audio " (De Boeck Supérieur, 2025).J'ai interviewé mon éditrice (Marie-Amélie Eglebienne) afin de partager avec vous le processus de création du livre.Comment est né le concept?Comment se passe la création d'un livre de A à Z?Quels sont les points forts de ce livre?Rejoins le SPRINT DE VOCABULAIRE, on démarre le 29 septembre 2025!https://www.sicomprendo.net/sprintvocabulaire/Si tu as zappé cette période d'inscription, abonne-toi à la newsletter pour que je te prévienne de façon prioritaire de l'ouverture des inscriptions de la nouvelle édition du SPRINT DE VOCABULAIRE.La newsletter.

Bienvenue dans la mini-série estivale sur comment mémoriser le vocabulaire en espagnol efficacement pour arrêter de chercher ses mots.Dans ce cinquième et dernier épisode je te présente ma toute nouvelle formation SPRINT DE VOCABULAIRE que j'ai créé autour de mon premier livre "Vocabulaire espagnol A1-A2 en 1000 mots: 200 cartes mentales et en audio " (De Boeck Supérieur, 2025).Profite de l'OFFRE ÉCLAIR avant le lundi 18 août.Si tu as zappé cette période d'inscription, abonne-toi à la newsletter pour que je te prévienne de façon prioritaire de l'ouverture des inscriptions de la nouvelle édition du SPRINT DE VOCABULAIRE.La newsletter.

Bienvenue dans la mini-série estivale sur comment mémoriser le vocabulaire en espagnol efficacement pour arrêter de chercher ses mots.Dans ce quatrième épisode je te présente mon premier livre "Vocabulaire espagnol A1-A2 en 1000 mots: 200 cartes mentales et en audio " (De Boeck Supérieur, 2025).Pour le commander sur le site de la maison d'édition c'est ici.Pour le commander sur Amazon.Bonne écoute! Et pense à le partager s'il t'a paru utile!

Bienvenue dans la mini-série estivale sur comment mémoriser le vocabulaire en espagnol efficacement pour arrêter de chercher ses mots.Dans ce troisième épisode tu vas auto-évaluer ton niveau d'espagnol grâce à 5 défis de vocabulaire. Chaque capsule comprend un conseil pratique et un défi facile à mettre en place rapidement.Bonne écoute! Et pense à le partager s'il t'a paru utile!

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/targeting-cause-emerging-therapies-menopausal-vms-10267SummaryThis enduring podcast activity explores groundbreaking advancements in the treatment of menopausal vasomotor symptoms (VMS), emphasizing non-hormonal therapies. Dr. Andrea Singer and Dr. Genevieve Neal-Perry discuss the underlying biology of menopause, particularly the role of neurokinin (NK) receptors, and introduces the science behind new therapeutic agents, as well as their clinical trial data.This podcast was recorded and is being used with permission of the presenters.Learning ObjectiveDiscuss the clinical trial data for new and emerging non-hormonal therapiesThis activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0.25 hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is supported in part by an educational grant from Bayer HealthCare Pharmaceuticals Inc.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/personalizing-care-identifying-the-right-patients-for-new-treatments-10268SummaryDr. Genevieve Neal-Perry and Dr. Andrea Singer focus on practical strategies in the personalized management of menopausal vasomotor symptoms (VMS). The discussion covers the importance of routine and individualized screening for VMS, with attention to healthcare disparities and the diverse ways menopause is discussed and experienced across populations, before covering patient selection criteria for newer non-hormonal treatments.This podcast was recorded and is being used with permission of the presenters.Learning ObjectivesIntegrate routine and individualized screening methods to identify patients with menopausal VMS, with attention to healthcare disparitiesIntegrate new and emerging agents into the treatment of women with menopausal VMS, based on patient characteristics and preferenceThis activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0 hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is supported in part by an educational grant from Bayer HealthCare Pharmaceuticals Inc.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Bienvenue dans la mini-série estivale sur comment mémoriser le vocabulaire en espagnol efficacement pour arrêter de chercher ses mots.Dans ce deuxième épisode épisode tu vas découvrir la clé pour passer de "je cherche trop mes mots en espagnol" à "je suis capable de faire des phrases sans réfléchir".Chaque capsule comprend un conseil pratique et un défi facile à mettre en place rapidement.Bonne écoute! Et pense à le partager s'il t'a paru utile!

Bienvenue dans la mini-série estivale sur comment mémoriser le vocabulaire en espagnol efficacement pour arrêter de chercher ses mots.Dans ce premier épisode tu vas découvrir la clé pour éviter les trous de mémoire quand tu parles espagnol. Si tu as l'impression de connaître le vocabulaire, mais de rester bloqué au moment de faire des phrases, c'est épisode est fait pour toi.Chaque capsule comprend un conseil pratique et un défi facile à mettre en place rapidement.Bonne écoute! Et pense à le partager s'il t'a paru utile!

J'ai changé le nom du podcast, pas pour faire joli, mais parce que je ne pouvais plus continuer à me lisser pour coller aux attentes.Ce que tu vas entendre ici, ce ne sont pas des hacks, pas des recettes, ni des injonctions emballées dans un joli branding.Ce podcast, c'est une permission de...Faire différemment.Ralentir sans culpabiliser.Construire un business qui te ressemble même s'il ne coche plus toutes les cases.Abonne-toi si tu sens que c'est le moment de faire autrement !!Et si tu penses à une femme qui n'en peut plus de devoir prouver, partage-lui cet épisode

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/strategies-and-real-world-impact-of-the-stimulant-crisis-10220SummaryThe stimulant medication shortage has introduced new challenges in managing ADHD, affecting both patients' access to essential treatments and clinicians' ability to provide consistent care. In this PsychTalk podcast/webcast episode, Drs. Gregory Mattingly and Roger McIntyre explore the impact of these shortages, particularly on cognitive functioning, treatment continuity, and daily life for individuals with ADHD. Their discussion also examines stimulant misuse and diversion, looking at trends in medication sourcing, formulations most susceptible to abuse, and strategies to reduce the risk of misuse. By the end of the episode, learners will be equipped with timely insights and real-world tools to optimize ADHD management amid evolving supply and safety challenges.This podcast was recorded and is being used with permission of the presenters.Learning ObjectivesAt the conclusion of this activity, participants should be better able to:Describe the impact of stimulant shortages on individuals with ADHDIncorporate best-practice clinical strategies to minimize the risk of stimulant misuse in the treatment of ADHDThis activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which includes 0.50 hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis activity is not supported by an educational grant.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:http://mycme.com/courses/the-cognitive-side-of-major-depressive-disorder-10221SummaryDespite significant improvements in mood symptoms, many patients with MDD continue to experience persistent residual symptoms—particularly cognitive impairments—that hinder full functional recovery. In this PsychTalk podcast/webcast episode, Drs. Gregory Mattingly and Roger McIntyre discuss the often-overlooked role of cognitive dysfunction in MDD recovery, highlighting how these impairments correlate strongly with reduced workplace productivity, social withdrawal, and elevated relapse risk, ultimately impeding long-term outcomes. Their conversation provides listeners with an in-depth understanding of the presentation of cognitive impairment and residual symptoms in MDD, as well as strategies to foster resilience, enhance patient engagement, and promote functional recovery.This podcast was recorded and is being used with permission of the presenters.Learning ObjectivesAt the conclusion of this activity, participants should be better able to:Recognize the clinical significance of residual symptoms in MDD, with a focus on cognitive impairment, and their impact on patient functioning and treatment outcomesThis activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.75 contact hours (which includes 0.25 hours of pharmacology).Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/the-latest-data-in-ckd-progression-10197SummaryEmerging evidence highlights the potential of GLP-1 receptor agonists (GLP-1 RAs) to slow CKD progression and reduce cardiovascular and kidney-related mortality in patients with type 2 diabetes (T2D) and chronic kidney disease (CKD). Yet, despite updated guidelines, these therapies remain underused. This program will explore the latest clinical data supporting the role of GLP-1 RAs in risk mitigation and provide practical strategies for implementing guideline-based treatment to reduce cardio-renal risk and improve outcomes in patients with T2D and CKD.This podcast was recorded and is being used with permission of the presenters.Learning ObjectivesAt the conclusion of this activity, participants should be better able to:Discuss emerging data on GLP-1 RA therapy for CKD progression in T2DImplement guideline-based care to minimize CV risk and CKD progressionThis activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0.25 hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis activity is supported by an educational grant from Novo Nordisk.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Dans cette vidéo, je te partage comment identifier les actions qui te donnent VRAIMENT de l'énergie – celles qui te rechargent au lieu de t'épuiser.Et pourquoi, selon moi, c'est le cheatcode ultime pour tout entrepreneur, qu'il débute ou qu'il soit déjà bien lancé.Dis-moi en commentaire ce que t'en penses

Je te propose un extrait du "CHALLENGE: débloquer ton espagnol pour oser parler avec les natifs sans stress" qui vient de se terminer.C'est un extrait du 4e LIVE dans lequel je partageais les 6 piliers à maîtriser pour passer de débutant à intermédiaire en espagnol, ainsi que le plan d'action à suivre.Pour recevoir le REPLAY, abonne-toi à la newsletter ici.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/answers-in-chronic-spontaneous-urticaria-10190SummaryIn this short CE/CME activity, moderator Dr. Brad Glick works with dermatology expert Dr. Gil Yosipovitch to answer your top questions regarding chronic spontaneous urticaria, as gathered from the 2025 NACE Conversations in Dermatology symposium. Questions cover diagnosis, treatment individualization, and more!Learning ObjectivesAt the conclusion of this activity, participants should be better able to:Assess the disease burden and impact on QoL in patients with CSUEvaluate current and emerging therapies for CSUThis activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0.25 hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis activity is supported by an independent educational grant from Sanofi and Regeneron Pharmaceuticals.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Pour retrouver l'ouvrage du Pr Philip https://www.albin-michel.fr/antideprime-9782226494207______Vidéo produite par HugoDecrypteEntretien écrit et mené par Hugo TraversAvec la participation du Pr Pierre PhilipJournalistes : Samy Rabbata Hugo TraversDirectrice de production : Marie DelvalléeChargé de production : Clément ChauletAssistants de production : Noé Périquet, Amandine BarCadreurs : Vanon Borget, Benjamin CarrionIngénieure du son : Inês Dos SantosMaquilleuse : Kim DesnoyersMonteuse : Manon LanglaisÉtalonnage : Toutes voiles dehors - Hugues DardartMiniature : Oncle SidMixage : Florent SimonHD MEDIA / UNFOLD PRODUCTION 2025 Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.

Beaucoup de francophones rêvent d'avoir un jour une résidence secondaire en Espagne, soit parce qu'ils voyagent régulièrement dans le pays, soit pour préparer leur retraite au soleil.Dans cet interview, Bernadette (élève de mon école d'espagnol en ligne depuis 2023) nous raconte son processus d'achat de résidence secondaire en Espagne et comment ce projet a motivé son désir de se mettre sérieusement à l'espagnol.

Bienvenue dans l'épisode le plus troublant de Dans l'Ombre des Légendes. Ce soir, nous ne plongeons pas dans la fiction, mais dans une histoire vraie. Celle de Sarah, ancienne modératrice d'un forum aujourd'hui fermé. Tout a commencé avec un compte nommé Observer_7, un utilisateur qui postait des phrases étrangement personnelles et menaçantes.Au départ, ce n'était qu'un troll. Mais très vite, les messages sont devenus plus précis, plus intimes… comme s'il écoutait les pensées des membres. Des messages privés inquiétants, des révélations impossibles à connaître, et puis… ce message : “La fenêtre derrière toi est ouverte.”Cette histoire vraie d'horreur numérique explore les dangers de l'anonymat en ligne, la paranoïa numérique, et cette question effrayante : Et s'il ne s'agissait pas d'un humain ?Un podcast horreur 2025 à ne pas écouter seul, mêlant creepypasta réelle, harcèlement numérique, et paranormal digital.

In our season finale, recorded on June 9, 2025, we wrap up another great year of the CarriersEdge Podcast with a mix of updates, insights, and a look ahead. Mark and Jane discuss updates in the course catalogue, learning about layout tools like Adobe InDesign, and highlighting the benefits of reusing training content. Plus, they give you a sneak peek at our upcoming Inside webinar on the U.S. English language proficiency requirements. Sections include: - 00:00 - Season finale and course catalogue updates - 20:04 - Layout tools (Adobe InDesign) - 28:15 - The advantages of reusing content - 38:58 - The English Language Proficiency Requirements

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/copd-inflammation-exacerbations-your-questions-answered-10143SummaryRejoin the conversation on COPD, inflammation, and new and emerging agents as two of our expert faculty come together to answer your top questions. Questions submitted from the recent Conversations in Primary Care live virtual symposia guide the discussion as we dig a bit deeper on type 2 inflammation, changes in COPD management, and new and emerging agents – including recently approved biologic agents – for COPD.Learning ObjectivesAt the conclusion of this activity, participants should be better able to:Review the relationship between inflammation, exacerbation, and disease progression in COPD, noting different inflammatory endotypes of patients with COPDDiscuss recent evidence surrounding the use of biologic agents in the management of patients with COPD and type 2 inflammationIntegrate current guidelines with clinical data on new and emerging agents for the management of COPD, distinguishing patients with and without markers of type 2 inflammationThis activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0.25 hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc and Sanofi.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Le 28 avril 2025 une panne électrique à échelle nationale s'est produite en Espagne et au Portugal. Comment les Espagnols ont-ils vécu cet évènement?Pratique la compréhension orale en espagnol et apprends la conjugaison et le vocabulaire de façon naturelle avec une nouvelle histoire facile et d'actualité.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/psychiatric-therapeutics-in-a-digital-world-10096SummaryIn this PsychTalk podcast/webcast episode, Drs. Gregory Mattingly and Lisa Harding delve into the digital world and breakdown its effects on mental health—both positive and negative. By the end of the episode, learners will have a better understanding of the relationship between screen time, social media, and attention, including clinical pearls for how to harness prescription technology to enhance patient outcomes in ADHD and depression.This podcast was recorded and is being used with permission of the presenters.Learning ObjectivesAt the conclusion of this activity, participants should be better able to:Examine the relationship between social media and attentionIncorporate FDA-authorized digital therapeutics into ADHD and depression management plans based on current clinical evidenceThis activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which does not include hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is not commercially supported.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/clinical-updates-in-schizophrenia-10097SummaryIn this PsychTalk podcast/webcast episode, Drs. Gregory Mattingly and Lisa Harding go through the evolving landscape of schizophrenia treatments. Listen as they discuss the pros and cons of various second-generation antipsychotics, the science behind muscarinic modulation for psychosis, and recent updates in clozapine prescribing. At the end of the session, the doctors answer several audience questions to enhance your understanding of these developments and how they apply to clinical practice.This podcast was recorded and is being used with permission of the presenters.Learning ObjectivesAt the conclusion of this activity, participants should be better able to:Integrate recent clinical data on antipsychotic treatments and relapse prevention strategies into management plans for patients with schizophreniaDescribe the role of muscarinic modulation in psychosisThis activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.75 contact hours (which includes 0.75 hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is not commercially supported.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Bertrand Lesguillons vous présente les sorties au cinéma de "Thunderbolts*", "Les Règles de l'Art", "Tu ne Mentiras Point" et "Les Indomptés"

Bertrand Lesguillons vous présente les sorties au cinéma de "Thunderbolts*", "Les Règles de l'Art", "Tu ne Mentiras Point" et "Les Indomptés"

Bienvenue dans la nouvelle série d'épisodes spécial "interview aux anciens membres de Sí comprendo".Aujourd'hui j'ai la chance d'avoir un de mes meilleurs élèves. Il partage son parcours de débutant absolu en espagnol à intermédiaire. Il a commencé avec des méthodes autodidactes, jusqu'à ce qu'il a compris qu'il avait besoin d'être accompagné pour aller plus loin.

Découvrez ma formation en ligne sur les fondamentaux de l'accueil !Chers Insiders, Notre voyage dans l'expérience et l'excellence de service continue et je me réjouis de rencontrer des invités toujours plus passionnants. Ce Podcast n'en est encore qu'à son commencement, mais les retours que vous me partagez m'encouragent à continuer ce beau projet. Si vous souhaitez que j'aille à la rencontre de personnalités remarquables, dites-le moi sur mes différents réseaux et partons ensemble à leur rencontre. Je suis Maxime Blot, artisan hôtelier, et vous êtes sur Hospitality Insiders. Mon invité du jour est un expert du Marketing et de la communication, quoi de mieux pour compléter notre vision de l'expérience client ? Il a également une longue carrière dans l'entrepreneuriat et je peux dire sans me tromper que le développement durable est une valeur forte que nous partageons. Je suis heureux de l'accueillir et je me languis d'en savoir plus sur son parcours, bonjour Olivier Dufit. Notes et références : La coopérative The Originals, Human Hotels & Resorts Travelclick, fournisseur mondial de solutions pour les hôteliers OTA : Online Travel Agency GDS : Global Distribution System LMS : Learning Management System RSE : Responsabilité Sociétale des Entreprises PMS : Property Management System Livre : les quatre accords toltèques de Don Miguel Ruiz Linkedin : Olivier Dufit Email : olivier_dufit@yahoo.frSi cet épisode vous a passionné, rejoignez-moi sur :L'Hebdo d'Hospitality Insiders, pour ne rien raterL'Académie Hospitality Insiders, pour vous former aux fondamentaux de l'accueilLinkedin, pour poursuivre la discussionInstagram, pour découvrir les coulissesLa bibliothèque des invités du podcastMerci de votre fidélité et à bientôt !Distribué par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

Nombre d'étudiants se demandent comment pratiquer son espagnol avec les natifs pour débloquer leur oral ou pour entretenir leur niveau après avoir suivi une formation.Même si ce type d'échanges linguistiques ne remplacent en aucun cas le suivi d'un professeur expert, cela peut être une excellente manière de compléter ton apprentissage et de rester motivé dans la durée.Dans cet épisode je te lis une histoire active sur l'application "Senior Lingua", qui permet de participer à des échanges linguistiques avec des personnes âgées en Espagne. C'est une formule gagnant-gagnant: tu pratiques ton espagnol, et tu aide ces personnes à se sentir moins seules.Découvre l'application ici.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/characterizing-connected-conditions-in-psychiatry-10045SummaryIn this PsychTalk podcast/webcast episode, Drs. Gregory Mattingly and Lisa Harding discuss some of the complexities of mental health care: overlapping symptoms and differential diagnoses. Listeners will learn about the connections between certain psychiatric disorders and how symptom combinations may influence treatment and patient outcomes. The program will also review strategies to help with accurate diagnoses in complex patient presentations, teaching listeners how to take a thorough patient history and use that information to guide treatment decisions.This podcast was recorded and is being used with permission of the presenters.Learning ObjectivesAt the conclusion of this activity, participants should be better able to:Describe the impact of comorbid mental health diagnoses on patient outcomesEmploy strategies to aid in the differential diagnosis of patients who present with symptoms suggestive of multiple mental health conditionsThis activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which does not include hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is not commercially supported.Send us a text about this episode. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/practical-management-for-complex-psychiatric-cases-10046SummaryIn this PsychTalk podcast/webcast episode, Drs. Gregory Mattingly and Lisa Harding teach by case example. Listeners will hear an introduction to a complex patient presentation and then be taken through expert strategies to discern the correct diagnoses. The program will conclude with the same case example to tie together the education and demonstrate these strategies in practice.This podcast was recorded and is being used with permission of the presenters.Learning ObjectiveAt the conclusion of this activity, participants should be better able to:Apply evidence-based strategies to develop personalized treatment plans when managing patients with comorbid mental health disordersThis activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.75 contact hours (which does not include hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is not commercially supported.Send us a text about this episode. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Voici un extrait de la FÊTE DU PRINTEMPS que j'ai animé le dimanche 30 mars pour tous les abonnés à la newsletter.Ils on pu tester leurs connaissances d'espagnol avant de partir, et puis je leur ai présenté la nouvelle ÉDITION EN DIRECT DE "ESPAGNOL POUR VOYAGER".Je partage avec toi aujourd'hui un extrait qui te permettra d'expériementer le pouvoir des histoires pour acquérir les bases de l'espagnol naturellement avant de partir en voyage.Offre-toi cette expérience linguistique avant le 2 avril 2025 ici.(Si jamais tu écoutes cet épisode plus tard, tu pourras te procurer la version en autonomie tout de même qui te permettra également de faire tes premiers pas en espagnol de façon complètement libre et à ton rythme).

Je suis Anne Margalin, Créatrice de l'univers de Sweet Papi Podcast, fondatrice d'un centre de ressources positives pour les aidants où nous prenons soin de nous et de nos parents en perte d'autonomie, avec bienveillance et sourire 

✨ Rien n'est impossible à ceux qui rêvent assez grand. À vos rêves. ✨Aujourd'hui, je suis un petit peu émue de me relancer dans des épisodes solo. Après 7 ans de podcast, c'est un vrai retour aux sources. Les temps ont changé. Je change, j'évolue. Et j'ai envie de retrouver cet espace où je peux partager avec vous, sans filtre.Quand j'ai lancé ce podcast, j'étais concentrée à 400% sur Gemmyo. Mais j'avais besoin de me lancer dans autre chose que ma vie professionnelle. Ce podcast m'a complètement allégée à l'époque. Il m'a permis de prendre du recul, de réfléchir autrement.Les interviews ne disparaissent pas, loin de là mais j'ai aussi envie de vous parler directement, de vous emmener avec moi dans mes réflexions.Dans cet épisode, je partage avec vous 2 habitudes qui ont profondément changé ma manière de vivre et de travailler. Rien d'extravagant vous allez me dire, mais des ajustements simples qui ont eu un impact immense au fil du temps.Dites-moi si ce format vous plaît, si vous souhaitez m'entendre plus souvent en solo. Ce podcast existe grâce à vous, et vos retours sont précieux.Bonne écoute !

Voici un extrait de la MASTERCLASS "Automatiser les verbes fréquents pour des conversations plus fluides et sans blocages".Je t'explique comment les 4 schémas du modèle INSIGHTS peuvent s'appliquer à ton apprentissage de l'espagnol.Deviens BETA-TESTEUR du BUNDLE "DÉFI DE CONJUGAISON + GRAMÁTICA NO DRAMÁTICA" (offre flash disponible jusqu'au jeudi 13 mars 2025 à 12h heure de Paris).

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/management-approaches-for-eoe-9991SummaryThe American College of Gastroenterology has published the first new guidelines for the treatment of eosinophilic esophagitis (EoE) since 2013. In this CME/CE podcast, Drs. Paul Feuerstadt and Brooks Cash discuss these latest recommendations, reviewing the role of proton pump inhibitors, topical steroids, diet elimination, a biologic, and esophageal dilation in the management of this increasingly recognized condition.Learning ObjectivesAt the conclusion of this activity, participants should be better able to:Assess the efficacy and safety profile of approved agents for EoE, with a focus on swallowed corticosteroids, in the management of EoEApply evidence-based guidelines to optimize treatment outcomes and improve the quality of life for patients with EoEThis activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.50 contact hours (which includes 0.25 hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.Send us a text about this episode. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/on-the-lookout-for-eoe-9990SummaryIn this CME/CE podcast, two gastroenterologists discuss the increasing prevalence of eosinophilic esophagitis (EoE), our evolving understanding of its pathophysiology, and its varied clinical presentation. Drs. Brooks Cash and Paul Feuerstadt also review the need for early identification of the condition, and discuss the latest American College of Gastroenterology guideline for diagnosis.Learning ObjectiveAt the conclusion of this activity, participants should be better able to:Identify common clinical presentations and diagnostic challenges to facilitate early diagnosis of EoE in diverse patient populationsThis activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.50 contact hours (which includes 0 hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.Send us a text about this episode. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Fêtons l'épisode nº80 avec un nouveau quiz qui récapitule les contenus des épisodes 71-79, cette fois-ci en format DIRECT SUR YOUTUBE!S'abonner à la newsletter.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/exercise-for-mental-health-9983SummaryWe've heard it time and time again, exercise is of great importance to our physical health—but did you know it is also important to our mental health? An activity as simple as taking a daily walk can have a substantial positive impact on depression outcomes. Despite the widespread benefits of exercise, patients and providers may overlook its importance in treatment plans. This presentation focuses on the mental and physical benefits of exercise, drawing insights from published data and clinical experience.In this PsychTalk podcast/webcast episode, Dr. Gregory Mattingly and Dr. Gerald Maguire discuss the benefits of exercise on both physical and mental health. Throughout the episode, they go through the research that supports the benefits of exercise, as well as provide practical strategies to encourage your patients to adopt exercise into their lifestyles.This podcast was recorded and is being used with permission of the presenters.Learning ObjectivesAt the conclusion of this activity, participants should be better able to:Describe the impact of exercise on mental healthReview data from prospective studies investigating the relationship between exercise and depressionThis activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which does not include hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is not commercially supported.Send us a text about this episode. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/psychedelics-for-depression-9984SummaryIn this PsychTalk podcast/webcast episode, Drs. Gregory Mattingly and Gerald Maguire explore the emerging role of psychedelics in treating mental health conditions. Listeners will learn about the mechanisms of action of psychedelic therapeutics and gain insights into their effects on the brain and behavior. The program will also review recent clinical trial data on the efficacy of psychedelic treatments for major depressive disorder (MDD), as well as provide expert insights on how to discuss the future of psychedelics with patients.This podcast was recorded and is being used with permission of the presenters.Learning ObjectivesAt the conclusion of this activity, participants should be better able to:Describe the mechanism of action of psychedelic therapeuticsReview clinical trial data regarding the use of psychedelic treatments in MDDThis activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.75 contact hours (which includes 0.75 hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is not commercially supported.Send us a text about this episode. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Dans cet épisode je partage avec toi ma méthode en 3 pas facile et progressive pour retrouver le contrôle de ton agenda et réussir enfin à trouver le temps de te mettre à l'espagnol.Pour écouter la suite de l'audio-training gratuit, c'est par ici.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/managing-the-burden-of-hyperkalemia-9952SummaryIn this concise CME/CE podcast, a cardiologist and a family physician discuss risks associated with hyperkalemia in patients being treated for heart failure or chronic kidney disease (CKD)—including the risks that accompany down-titration or discontinuation of RAASi therapy.Drs. Javed Butler and Neil Skolnik provide guidance on which patients are most at risk and review the use of potassium binders that can manage hyperkalemia without compromising the crucial use of guideline-directed medical therapy (GDMT). By the end of this podcast episode, listeners will feel much more confident in their ability to safely and effectively address hyperkalemia in patients with heart failure or CKD.Learning ObjectivesAt the conclusion of this activity, participants should be better able to:Describe the disparities and clinical implications of hyperkalemia in patients with HF and CKD in terms of optimizing guideline-directed medical therapy (GDMT) and outcomesDiscuss the safety and effectiveness of potassium binders in reducing potassium and optimizing GDMT in patients with HF and CKDThis activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0 hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is supported by an educational grant from AstraZeneca Pharmaceuticals.Send us a text about this episode. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/using-newer-agents-in-chronic-hyperkalemia-management-9953SummaryIn this concise CME/CE podcast, a cardiologist and primary care physician review hyperkalemia management options that safely allow continuing GDMT for patients with heart failure or CKD. Using case examples, the clinicians provide education on individualizing treatment and addressing disparities in care.Learning ObjectiveAt the conclusion of this activity, participants should be better able to:Identify practical aspects of using potassium binders for treating hyperkalemia and optimizing GDMT to achieve equitable care for patients with HF and CKDThis activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0.25 hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is supported by an educational grant from AstraZeneca Pharmaceuticals.Send us a text about this episode. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/breakthroughs-of-mental-health-advances-9942SummaryWe saw a lot of changes in 2024, especially in the mental health/psychiatry space. Keeping up with the most current information and how it affects your practice can be challenging in this ever-changing landscape. This presentation aims to make this information more accessible to clinicians so that patients can receive the most up-to-date care.In this PsychTalk podcast/webcast episode, Dr. Gregory Mattingly and Dr. Gerald Maguire wrap up 2024 with a question-and-answer session focused on the latest advances in the mental health field. Listen as they go through questions covering major depressive disorder, ADHD, bipolar disorder, and schizophrenia.This podcast was recorded and is being used with permission of the presenters.Learning ObjectiveAt the conclusion of this activity, participants should be better able to:Review the latest advances in ADHD, MDD, bipolar disorder, and schizophreniaThis activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which includes 0.50 hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is not commercially supported.Send us a text about this episode. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/tick-tock-psych-expert-tips-on-complex-patient-management-9943SummaryMore often than not, patients present to clinicians with multiple diagnoses—complicating treatment decisions. Whether the comorbidities are related to psychiatric, cardiovascular, or neurologic etiologies, psychiatry clinicians need to know how to optimally manage patients in the face of such challenges. This presentation provides quick, to-the-point answers to audience questions regarding complex patient management.In this PsychTalk podcast/webcast episode, Dr. Gregory Mattingly and Dr. Gerald Maguire go against the clock to answer your questions on complex patient management in the psychiatry setting. They are given 2 minutes to answer each question, packing their expertise into small, bite-sized sections.This podcast was recorded and is being used with permission of the presenters.Learning ObjectiveAt the conclusion of this activity, participants should be better able to:Discuss psychiatric management considerations for patients with complex comorbidities in your clinical practice.This activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.75 contact hours (which includes 0.25 hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is not commercially supported.Send us a text about this episode. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/adult-adhd-diagnosis-and-management-9854SummaryAdult ADHD is a neurodevelopmental disorder that often persists from childhood into adulthood, affecting attention, impulsivity, and executive function. Despite increased awareness, ADHD in adults remains underdiagnosed and undertreated, presenting unique challenges in clinical practice. This presentation focuses on strategies to address these challenges, drawing insights from recent data and provides our experts recommendations.In this PsychTalk podcast/webcast episode, Dr. Gregory Mattingly and Dr. Vladimir Maletic discuss key findings from the CDC report on adult ADHD, including trends in prevalence, diagnostic gaps, and barriers to effective treatment. They also explore the latest research on gender differences in ADHD, emphasizing how these disparities impact diagnosis and treatment approaches. Our experts highlight the need for tailored strategies to ensure more accurate and effective care, especially given that women are often diagnosed later in life and may experience different symptom presentations than men.This podcast was recorded and is being used with permission of the presenters.Learning ObjectivesAt the conclusion of this activity, participants should be better able to:Review key insights from the CDC report regarding the prevalence, diagnosis trends, and treatment challenges of ADHD in adultsExamine the latest data on gender differences in ADHD diagnosis and treatmentThis activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which does not include hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is not commercially supported.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/streamlined-strategies-for-managing-tardive-dyskinesia-9842SummaryTardive dyskinesia (TD) is a debilitating movement disorder that manifests as involuntary, repetitive movements, often of the face, tongue, and extremities. These symptoms frequently result from prolonged use of antipsychotic medications, particularly in patients being treated for schizophrenia, bipolar disorder, or major depressive disorder. Accurate and routine assessment of TD is critical to prevent symptom progression and improve patient outcomes. The Abnormal Involuntary Movement Scale (AIMS) is a widely accepted, gold-standard tool used to detect and measure the severity of involuntary movements. AIMS enables clinicians to detect involuntary movements early and track the disorder's progression, facilitating timely intervention and individualized treatment plans.In this PsychTalk podcast/webcast episode, Dr. Gregory Mattingly and Dr. Vladimir Maletic delve into the complexities of diagnosing and managing tardive dyskinesia (TD), emphasizing evidence-based strategies to improve patient outcomes. They discuss the importance of using the Abnormal Involuntary Movement Scale (AIMS), a standardized and validated tool, for regular TD assessment. AIMS enables clinicians to detect involuntary movements early and track the disorder's progression, facilitating timely intervention and individualized treatment plans.Learning ObjectiveAt the conclusion of this activity, participants should be better able to:Explore strategies to simplify management and optimally improve outcomes for patients with TDThis activity is accredited for CME/CE CreditThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.75 contact hours (which includes 0.50 hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is supported by an educational grant from Neurocrine Biosciences.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

This podcast features an engaging discussion between Dr. Douglas Dieterich and his patient with long-standing PBC, on the patient's insights and experiences with her disease and treatment. The activity will enable participants to understand the importance of listening to patient perspectives when designing individualized care pathways to alleviate symptoms and improve quality of life.Launch Date: November 21, 2024Release Date: November 21, 2024Expiration Date: October 31, 2025FACULTYDouglas Dieterich, MDDirector, Institute for Liver Medicine at Mount SinaiProfessor of Medicine, Icahn School of Medicine at Mount SinaiThis podcast provides accredited continuing education credits.  To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.https://www.practicepointcme.com/CMEHome/patient-voices-in-primary-biliary-cholangitis-a-ce-podcast-series-to-recognize-challenges-reduce-disparities-and-improve-outcomes

This podcast features an engaging discussion between Dr. David Victor and his patient, with long-standing PBC, on the patient's insights and experiences with her disease and treatment. The activity will enable participants to understand the importance of listening to patient perspectives when designing individualized care pathways to alleviate symptoms and improve quality of life.Launch Date: October 24, 2024Release Date: October 24, 2024Expiration Date: September 30, 2025FACULTYDavid W. Victor III, MDAssociate Professor of Clinical MedicineHouston Methodist Research InstituteAssociate Professor of Clinical MedicineWeill Cornell MedicineThis podcast provides accredited continuing education credits.  To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.https://www.practicepointcme.com/CMEHome/patient-voices-in-primary-biliary-cholangitis-a-ce-podcast-series-to-recognize-challenges-reduce-disparities-and-improve-outcomes